FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs
Pull slowly
However, these should be used sparingly and under medical supervision to avoid dependency or worsening symptoms
(2021) Effect of Metabolaid on pre- and stage 1 hypertensive patients: A randomized controlled trial
How to Naturally Boost GLP-1: A Personalized Path to Satiety, Blood Sugar Balance, and Metabolic Health GLP-1, or glucagon-like peptide-1, is gaining mainstream attention thanks to the popularity of GLP-1 agonist drugs like Ozempic and Wegovy
The most commonly reported side effects are nausea, vomiting, diarrhea, constipation, and stomach pain